Patent details

Basic Information

Publication number:

EP2475371

PCT Application Number:

PCT/IL/2010/000729

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP107634560

PCT Publication Number:

WO/2011/027348

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITION COMPRISING A3 ADENOSINE RECEPTOR AGONIST (IB-MECA/CF-101) FOR TREATMENT OF PSORIASIS

French Title of Invention:

COMPOSITION PHARMACEUTIQUE COMPRENANT UN AGONIST DU RECEPTEUR A3 ADENOSINE (IB-MECA/CF-101) POUR LE TRAITEMENT DU PSORIASIS

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNG ENTHALTEND EINEN A3 ADENOSIN REZEPTOR AGONIST (IB-MECA/CF-101) FÜR DIE BEHANDLUNG VON PSORIASIS

SPC Number:

Dates

Filing date:

06/09/2010

Grant date:

23/11/2016

EP Publication Date:

23/11/2016

PCT Publication Date:

10/03/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/07/2012

EP B1 Publication Date:

23/11/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

06/09/2017

Expiration date:

06/09/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/09/2010

 

 

Name:

Can-Fite Biopharma Ltd.

Address:

10 Bareket Street P.O. Box 7537, Petach Tikva 49170, Israel (IL)

Inventor

Name:

FISHMAN Pnina

Address:

Israel (IL)

Priority

Priority Number:

20075309

Priority Date:

06/09/2009

Priority Country:

Israel (IL)

Classification

Main IPC Class:

A61K 31/7076;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages